No description available.

A modulação da resposta inflamatória uterina equina recebe atenção, devido a um distúrbio imunológico, que parece ocorrer em uma população de éguas, classificadas como suscetíveis à endometrite. O objetivo deste estudo foi verificar o efeito da corticoterapia aplicada na presença e na ausência de inflamação uterina sobre a proteômica e a concentração de óxido nítrico no líquido endometrial de éguas suscetíveis à endometrite. Éguas foram sincronizadas com 5 mg de prostaglandina F2α e após a verificação dos sinais de estro foram submetidas a quatro tratamentos. O primeiro foi o Controle, que não recebeu nenhum tipo de tratamento. O segundo foi o GC, onde as éguas receberam aplicação de um glicocorticóide, a cada 12 horas, por três dias consecutivos. O terceiro foi o Infectado, onde as éguas receberam uma infusão intrauterina de Streptococcus zoopepidemicus (1x109/mL) e o quarto foi o GC + Infectado, onde as éguas receberam a aplicação do glicocorticóide e a infusão intrauterina descrita acima. Doze horas após o final de cada tratamento, amostras de líquido endometrial puro e de lavados uterinos foram coletadas para análise proteômica e determinação de óxido nítrico, respectivamente. O primeiro artigo relata os dados preliminares da análise proteômica, com a contagem das bandas protéicas e a observação de 33 bandas protéicas no Controle, 54 no GC, 51 no Infectado e 72 no GC + Infectado. A corticoterapia pode induzir o aparecimento de um número maior de bandas protéicas, pois os géis com as maiores contagens foram nos tratamentos onde ela foi aplicada. No segundo artigo, foi realizada a identificação das bandas protéicas significativas, em relação à densidade óptica relativa e à frequência. A corticoterapia provocou uma alteração na proteômica do líquido endometrial, caracterizada pelo aumento e diminuição na densidade óptica relativa e na frequência de proteínas da fase aguda da inflamação, com as maiores alterações observadas quando a corticoterapia foi aplicada na presença do processo infeccioso. A infusão de Streptococcus zooepidemicus provocou alterações na proteômica do líquido endometrial, caracterizadas pelo aumento e diminuição na densidade óptica relativa e na frequência de proteínas da fase aguda da inflamação. Os resultados do estudo indicam que a corticoterapia provoca alterações imunológicas no endométrio equino, não apenas como depressiva, mas estimuladora da defesa local, através de uma ação imunomoduladora. No terceiro artigo, foi realizada a determinação da concentração de óxido nítrico, não sendo observada diferença significativa nos quatro tratamentos. Portanto, a corticoterapia provoca alterações proteômicas no líquido endometrial de éguas suscetíveis em estro, onde a presença de um estímulo inflamatório causado pela infusão intrauterina bacteriana induz a uma maior alteração, do que a ausência. A infecção do lúmen uterino provoca alterações proteômicas no líquido endometrial e a corticoterapia não influencia a concentração de óxido nítrico de éguas em estro. / The modulation of the equine uterine inflammatory response recieves much attention, due to an immunological disorder, which appears to happen in a population of mares, classified as suscetipble to endometritis. The aim of this study was to verify the effect of corticotherapy applied in the presence and in the absence of uterine inflammation on the proteomics and nitric oxide concentration of the endometrial fluid of mares susceptible to endometritis. Mares were synchronized with 5 mg prostaglandin F2α and after the observation of the signs of estrus were submitted to four treatments. The first was the Control, which did not recieve any kind of treatment. The second was the GC, where mares recieved the administration of a glucocorticoid, each 12 hours, for three consecutive days. The third was the Infected, where mares received an intrauterine infusion of Streptococcus zoopepidemicus (1x109/mL) and the fourth was the GC + Infected, where mares received the administration of glucocorticoid and intrauterine infusion as described above. Twelve hours after the end of each treatment, pure endometrial fluid and uterine flushings were collected for proteomic analysis and nitric oxide determination, respectively. The first article reports the preliminary data of the proteomic analysis, where protein band counts were done, being observed 33 protein bands in Control, 54 in GC, 51 in Infected and 72 in GC + Infected. Corticotherapy can induce the appearance of a higher number of protein bands, because the gels with the highest counts were in the treatments where it was applied. In the second article, the identification of the significative protein bands was done, regarding the relative optic density and frequency. Corticotherapy provoked an alteration in the endometrial proteomics, characterized by an increase and a decrease on the relative optic density and frequency of inflammatory acute phase proteins, with the major alterations observed when corticotherapy was applied in the presence of an infectious process. Streptococcus zooepidemicus infusion provoked alterations in the endometrial fluid proteomics, characterized by an increase and a decrease on the relative optic density and frequency of inflammatory acute phase proteins. Results from this study indicate that corticotherapy provokes immunological alterations in the equine endometrium, not only as depressor, but enhancer of local defense, through an immunomodulatory action. In the third article, the nitric oxide concentration was determined, with no significative diference observed in the four treatments. So, corticotherapy provokes alterations in the proteomics of the endometrial fluid of susceptible mares in estrus, where the presence of an inflammatory stimulus caused by intrauterine bacterial infusion induces a major alteration, than the absence. Uterine lumen infection provokes alterations in the proteomics of the endometrial fluid and corticotherapy does not influence nitric oxide concentration in mares in estrus.

A modulação da resposta inflamatória uterina equina recebe atenção, devido a um distúrbio imunológico, que parece ocorrer em uma população de éguas, classificadas como suscetíveis à endometrite. O objetivo deste estudo foi verificar o efeito da corticoterapia aplicada na presença e na ausência de inflamação uterina sobre a proteômica e a concentração de óxido nítrico no líquido endometrial de éguas suscetíveis à endometrite. Éguas foram sincronizadas com 5 mg de prostaglandina F2α e após a verificação dos sinais de estro foram submetidas a quatro tratamentos. O primeiro foi o Controle, que não recebeu nenhum tipo de tratamento. O segundo foi o GC, onde as éguas receberam aplicação de um glicocorticóide, a cada 12 horas, por três dias consecutivos. O terceiro foi o Infectado, onde as éguas receberam uma infusão intrauterina de Streptococcus zoopepidemicus (1x109/mL) e o quarto foi o GC + Infectado, onde as éguas receberam a aplicação do glicocorticóide e a infusão intrauterina descrita acima. Doze horas após o final de cada tratamento, amostras de líquido endometrial puro e de lavados uterinos foram coletadas para análise proteômica e determinação de óxido nítrico, respectivamente. O primeiro artigo relata os dados preliminares da análise proteômica, com a contagem das bandas protéicas e a observação de 33 bandas protéicas no Controle, 54 no GC, 51 no Infectado e 72 no GC + Infectado. A corticoterapia pode induzir o aparecimento de um número maior de bandas protéicas, pois os géis com as maiores contagens foram nos tratamentos onde ela foi aplicada. No segundo artigo, foi realizada a identificação das bandas protéicas significativas, em relação à densidade óptica relativa e à frequência. A corticoterapia provocou uma alteração na proteômica do líquido endometrial, caracterizada pelo aumento e diminuição na densidade óptica relativa e na frequência de proteínas da fase aguda da inflamação, com as maiores alterações observadas quando a corticoterapia foi aplicada na presença do processo infeccioso. A infusão de Streptococcus zooepidemicus provocou alterações na proteômica do líquido endometrial, caracterizadas pelo aumento e diminuição na densidade óptica relativa e na frequência de proteínas da fase aguda da inflamação. Os resultados do estudo indicam que a corticoterapia provoca alterações imunológicas no endométrio equino, não apenas como depressiva, mas estimuladora da defesa local, através de uma ação imunomoduladora. No terceiro artigo, foi realizada a determinação da concentração de óxido nítrico, não sendo observada diferença significativa nos quatro tratamentos. Portanto, a corticoterapia provoca alterações proteômicas no líquido endometrial de éguas suscetíveis em estro, onde a presença de um estímulo inflamatório causado pela infusão intrauterina bacteriana induz a uma maior alteração, do que a ausência. A infecção do lúmen uterino provoca alterações proteômicas no líquido endometrial e a corticoterapia não influencia a concentração de óxido nítrico de éguas em estro. / The modulation of the equine uterine inflammatory response recieves much attention, due to an immunological disorder, which appears to happen in a population of mares, classified as suscetipble to endometritis. The aim of this study was to verify the effect of corticotherapy applied in the presence and in the absence of uterine inflammation on the proteomics and nitric oxide concentration of the endometrial fluid of mares susceptible to endometritis. Mares were synchronized with 5 mg prostaglandin F2α and after the observation of the signs of estrus were submitted to four treatments. The first was the Control, which did not recieve any kind of treatment. The second was the GC, where mares recieved the administration of a glucocorticoid, each 12 hours, for three consecutive days. The third was the Infected, where mares received an intrauterine infusion of Streptococcus zoopepidemicus (1x109/mL) and the fourth was the GC + Infected, where mares received the administration of glucocorticoid and intrauterine infusion as described above. Twelve hours after the end of each treatment, pure endometrial fluid and uterine flushings were collected for proteomic analysis and nitric oxide determination, respectively. The first article reports the preliminary data of the proteomic analysis, where protein band counts were done, being observed 33 protein bands in Control, 54 in GC, 51 in Infected and 72 in GC + Infected. Corticotherapy can induce the appearance of a higher number of protein bands, because the gels with the highest counts were in the treatments where it was applied. In the second article, the identification of the significative protein bands was done, regarding the relative optic density and frequency. Corticotherapy provoked an alteration in the endometrial proteomics, characterized by an increase and a decrease on the relative optic density and frequency of inflammatory acute phase proteins, with the major alterations observed when corticotherapy was applied in the presence of an infectious process. Streptococcus zooepidemicus infusion provoked alterations in the endometrial fluid proteomics, characterized by an increase and a decrease on the relative optic density and frequency of inflammatory acute phase proteins. Results from this study indicate that corticotherapy provokes immunological alterations in the equine endometrium, not only as depressor, but enhancer of local defense, through an immunomodulatory action. In the third article, the nitric oxide concentration was determined, with no significative diference observed in the four treatments. So, corticotherapy provokes alterations in the proteomics of the endometrial fluid of susceptible mares in estrus, where the presence of an inflammatory stimulus caused by intrauterine bacterial infusion induces a major alteration, than the absence. Uterine lumen infection provokes alterations in the proteomics of the endometrial fluid and corticotherapy does not influence nitric oxide concentration in mares in estrus.

-

Les incidences de l’écoulement vaginal purulent (EVP) et de l’endométrite cytologique (EC) sont élevées dans les exploitations laitières à cause des contaminations utérines associées à l’immunosuppression péripartum. Le pegbovigrastim (bG-CSF) a été approuvé dans la prévention de la mammite clinique chez les vaches en postpartum. L’objectif de cette étude était d’évaluer l’efficacité du bG-CSF dans la prévention de l’EVP et de l’EC chez les vaches laitières en postpartum. Dans un essai contrôlé randomisé, 60 vaches laitières en postpartum ont été enrôlées et réparties dans deux groupes (saline, n = 29 ; bG-CSF, n = 31) où chaque vache a reçu deux injections de traitement en sous-cutané aux 14e et 21e jours en lait (JEL) au creux de la croupe. L’EVP et l’EC ont été diagnostiqués chez les vaches ayant des scores de pus ≥ 3, d’estérase leucocytaire ≥ 1 ou de neutrophiles ≥ 6%. Toutes les réponses immunitaires utérines et les prévalences de l’endométrite étaient plus importantes numériquement dans le groupe bG-CSF, mais ne différaient pas statistiquement de celles du groupe saline. Les résultats étaient aussi non-différents statistiquement pour les performances subséquentes en reproduction et survie dans le troupeau. En conclusion, le traitement au bG-CSF ne semble pas efficace pour prévenir l’EVP et l’EC. Cependant, pour des raisons d’absence de différence significative constaté dans nos résultats, nous recommandons la poursuite de l’étude avec au moins une puissance statistique de 80% et un niveau de confiance de 95% afin de mieux conclure sur l’efficacité de bG-CSF contre l’endométrite. / The incidences of purulent vaginal discharge (PVD) and cytological endometritis (CE) are high in dairy farms because of uterine contamination associated with peripartum immunosuppression. Pegbovigrastim (bG-CSF) has been approved for the prevention of clinical mastitis in postpartum dairy cows. The objective of this study was to evaluate the efficacy of bG-CSF in the prevention of PVD and CE in postpartum dairy cows on the 35th day postpartum. In a randomized controlled trial, 60 postpartum dairy cows were enrolled and divided into two groups (saline, n = 29; bG-CSF, n = 31) where each cow had received two injections subcutaneously on the 14th and 21st days postpartum at the base of the tail. PVD and CE were diagnosed in cows at with scores of pus ≥ 3 and leukocyte esterase ≥ 1 or neutrophils ≥ 6%, respectively. bG-CSF group but did not differ statistically from those of the saline group (p>0.05). Differences were also not significant for subsequent performance of cows in reproduction parameters and survival in the herd. In conclusion, bG-CSF treatment did not seem effective in preventing PVD and CE in dairy cows. However, for reasons of absence of significant difference observed in our results, we recommend the continuation of the study with at least a statistical power of 80% and a level of confidence of 95% in order to better conclude on the effectiveness of bG-CSF against endometritis.

La reproduction est un pilier majeur de la productivité des fermes laitières. Dans ce contexte, il est pertinent d’identifier à l’avance les animaux à risque d’avoir des performances en reproduction sous-optimales, surtout si un traitement efficace est disponible pour améliorer ces performances. Les endométrites clinique et subclinique sont des conditions définies selon leur impact sur les performances en reproduction subséquentes et donc, des outils très intéressants de surveillance de la santé utérine. Le premier objectif de cette étude était de déterminer simultanément des seuils diagnostiques pour les endométrites clinique (diagnostiquée par le Metricheck) et subclinique (diagnostiquée par la cytologie endométriale ou par l’estérase leucocytaire) selon leur impact sur les performances en reproduction à la première saillie. L’écoulement vaginal purulent a été identifié comme seuil pour l’endométrite clinique, alors que les seuils identifiés pour l’endométrite subclinique ont été un pourcentage de polymorphonucléaires de 6% à la cytologie et une « forte quantité de leucocytes » à l’estérase leucocytaire. Le second objectif de l’étude était d’évaluer l’effet d’un traitement intra-utérin de céphapirine sur les performances à la première saillie des animaux sains et atteints d’endométrite. Aucun effet du traitement n’a été observé chez les vaches saines ou atteintes d’endométrite clinique, alors qu’une tendance à l’amélioration des performances a été associée au traitement chez celles atteintes d’endométrite subclinique. L’anovulation post-partum prolongée pourrait altérer l’efficacité du traitement de céphapirine, surtout chez les vaches atteintes d’endométrite clinique. / Reproduction is a major concern in the dairy industry. In this context, it is relevant to have an early identification of cows at risk of altered subsequent reproductive performance, especially if a treatment is available and effective to improve this performance. Clinical and subclinical endometritis are defined based on their impact on reproductive performance and are interesting tools for reproductive tract health surveillance. The first objective of this research project was to determine simultaneously diagnostic criteria for clinical (diagnosed by Metricheck) and subclinical (diagnosed by endometrial cytology or leukocyte esterase testing) endometritis based on their impact on reproductive performance at first service. Clinical endometritis was defined as presence of purulent vaginal discharge whereas subclinical endometritis was defined as presence of ≥ 6% of polymorphonuclear cells using endometrial cytology or the presence of “large amount of leukocytes” using leukocyte esterase testing. The second objective of this research project was to determine the effect of an intrauterine infusion of cephapirin on the reproductive performance at first service in cows with clinical endometritis, subclinical endometritis, and in cows unaffected by endometritis. Cephapirin treatment had no effect on first service pregnancy risk in unaffected cows or in cows affected by clinical endometritis. However, there was a tendency of a positive effect of the treatment in cows affected by subclinical endometritis. Presence of prolonged postpartum anovulation in cows may reduce the efficacy of the cephapirin treatment, especially in cows affected by clinical endometritis.

La reproduction est un pilier majeur de la productivité des fermes laitières. Dans ce contexte, il est pertinent d’identifier à l’avance les animaux à risque d’avoir des performances en reproduction sous-optimales, surtout si un traitement efficace est disponible pour améliorer ces performances. Les endométrites clinique et subclinique sont des conditions définies selon leur impact sur les performances en reproduction subséquentes et donc, des outils très intéressants de surveillance de la santé utérine. Le premier objectif de cette étude était de déterminer simultanément des seuils diagnostiques pour les endométrites clinique (diagnostiquée par le Metricheck) et subclinique (diagnostiquée par la cytologie endométriale ou par l’estérase leucocytaire) selon leur impact sur les performances en reproduction à la première saillie. L’écoulement vaginal purulent a été identifié comme seuil pour l’endométrite clinique, alors que les seuils identifiés pour l’endométrite subclinique ont été un pourcentage de polymorphonucléaires de 6% à la cytologie et une « forte quantité de leucocytes » à l’estérase leucocytaire. Le second objectif de l’étude était d’évaluer l’effet d’un traitement intra-utérin de céphapirine sur les performances à la première saillie des animaux sains et atteints d’endométrite. Aucun effet du traitement n’a été observé chez les vaches saines ou atteintes d’endométrite clinique, alors qu’une tendance à l’amélioration des performances a été associée au traitement chez celles atteintes d’endométrite subclinique. L’anovulation post-partum prolongée pourrait altérer l’efficacité du traitement de céphapirine, surtout chez les vaches atteintes d’endométrite clinique. / Reproduction is a major concern in the dairy industry. In this context, it is relevant to have an early identification of cows at risk of altered subsequent reproductive performance, especially if a treatment is available and effective to improve this performance. Clinical and subclinical endometritis are defined based on their impact on reproductive performance and are interesting tools for reproductive tract health surveillance. The first objective of this research project was to determine simultaneously diagnostic criteria for clinical (diagnosed by Metricheck) and subclinical (diagnosed by endometrial cytology or leukocyte esterase testing) endometritis based on their impact on reproductive performance at first service. Clinical endometritis was defined as presence of purulent vaginal discharge whereas subclinical endometritis was defined as presence of ≥ 6% of polymorphonuclear cells using endometrial cytology or the presence of “large amount of leukocytes” using leukocyte esterase testing. The second objective of this research project was to determine the effect of an intrauterine infusion of cephapirin on the reproductive performance at first service in cows with clinical endometritis, subclinical endometritis, and in cows unaffected by endometritis. Cephapirin treatment had no effect on first service pregnancy risk in unaffected cows or in cows affected by clinical endometritis. However, there was a tendency of a positive effect of the treatment in cows affected by subclinical endometritis. Presence of prolonged postpartum anovulation in cows may reduce the efficacy of the cephapirin treatment, especially in cows affected by clinical endometritis.